Infectious Disease

Cytomegalovirus DNA levels predict CMV disease after kidney transplants

Published in TB and Outbreaks Week, September 24th, 2002

by Michael Greer, senior medical writer - Molecular testing for cytomegalovirus (CMV) can help determine patients at risk of developing CMV disease after kidney transplantation, researchers in Norway report.

Halvor Rollag and colleagues working at the University of Oslo Hospital evaluated the prognostic value of three CMV blood tests for kidney transplant patients.

The quantitative DNA test provided the most useful results, Rollag and coauthors found.

The researchers compared a test for CMV's pp65 antigen in leukocytes with two molecular assays, a quantitative and a qualitative polymerase chain reaction (PCR) CMV plasma screen. A...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-09-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry